PERCEPTIVE ADVISORS LLC – Neurocrine Biosciences, Inc. Transaction History
PERCEPTIVE ADVISORS LLC portfolio value:
$10.62M
portfolio value
PERCEPTIVE ADVISORS LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -74.85% | -297.83K shares | -28.16M | $106.21 | 100.05K |
Q2 2022 | share | Increase | +0.57% | 2.24K shares | 1.69M | $97.48 | 397.88K |
Q1 2022 | share | Decrease | -18.09% | -87.36K shares | -4.04M | $93.75 | 395.63K |
Q4 2021 | share | 0.00% | 0 shares | -5.18M | $84.63 | 483.00K | |
Q3 2021 | share | Decrease | -40.50% | -328.82K shares | -32.68M | $95.91 | 483.00K |
Q2 2021 | share | Decrease | -13.80% | -130K shares | -12.58M | $97.32 | 811.83K |
Q1 2021 | share | Decrease | -50.41% | -957.38K shares | -90.44M | $97.25 | 941.83K |
Q4 2020 | share | Increase | +22.63% | 350.5K shares | 33.11M | $95.85 | 1.89M |
Q3 2020 | share | Decrease | -27.68% | -592.69K shares | -112.32M | $96.16 | 1.54M |
Q2 2020 | share | Decrease | -30.09% | -921.85K shares | -3.87M | $122 | 2.14M |
Q1 2020 | share | Decrease | -15.21% | -549.29K shares | -123.18M | $86.55 | 3.06M |
Q4 2019 | share | Decrease | -11.02% | -447.34K shares | 22.47M | $107.49 | 3.61M |
Q3 2019 | share | Increase | +0.90% | 36.03K shares | 26.10M | $90.11 | 4.05M |
Q2 2019 | share | Increase | +7.06% | 265.2K shares | 8.59M | $84.43 | 4.02M |
Q1 2019 | share | Decrease | -18.44% | -849.89K shares | 15.77M | $88.1 | 3.75M |
Q4 2018 | share | Decrease | -3.53% | -168.7K shares | -272M | $71.41 | 4.60M |
Q3 2018 | share | Increase | +1.31% | 62.00K shares | 124.13M | $122.95 | 4.77M |
Q2 2018 | share | Decrease | -0.98% | -46.73K shares | 68.31M | $98.24 | 4.71M |
Q1 2018 | share | Decrease | -7.56% | -389.6K shares | -4.8M | $82.93 | 4.76M |
Q4 2017 | share | Increase | +7.51% | 360K shares | 106.08M | $77.59 | 5.15M |
Q3 2017 | share | Increase | +33.93% | 1.21M shares | 129.06M | $61.28 | 4.79M |
Q2 2017 | share | Increase | +6.27% | 211.05K shares | 18.79M | $46 | 3.57M |
Q1 2017 | share | Increase | +1.51% | 50.00K shares | 17.42M | $43.3 | 3.36M |
Q4 2016 | share | Increase | +33.93% | 840.25K shares | 2.95M | $38.7 | 3.31M |
Q3 2016 | share | Decrease | -11.50% | -321.69K shares | -1.76M | $50.64 | 2.47M |
Q2 2016 | share | Increase | +2.83% | 77K shares | 19.55M | $45.45 | 2.79M |
Q1 2016 | share | Increase | +9.01% | 224.8K shares | -33.59M | $39.55 | 2.72M |